This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here

IMRA Insider Trading (IMARA)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $7,750,000.00
Insider Selling (Last 12 Months): $124,975.00

IMARA Insider Trading History Chart

IMARA Share Price & Price History

$12.50
▼ -0.4 (-3.10%)
As of 02/25/2021 01:00 AM ET
Days: 30 | 90 | 365
Are you looking for the next great pet stock play?
Don't miss this opportunity as FRPT is already trading over 100 dollars per share!
Read more here about the next great pet stock!

IMARA Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2020Rahul D BallalCEOSell4,999$25.00$124,975.004,999  
3/16/2020Barbara DaltonDirectorBuy312,500$15.50$4,843,750.00
3/16/2020Bioscience Plc ArixMajor ShareholderBuy187,500$15.50$2,906,250.00
See Full Table

SEC Filings (Institutional Ownership Changes) for IMARA (NASDAQ:IMRA)

64.53% of IMARA stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

IMARA Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/19/2021JPMorgan Chase & Co.20,514$0.45M0.0%+560.3%0.118%
2/16/2021Charles Schwab Investment Management Inc.35,146$0.78M0.0%+10.1%0.202%
2/13/2021American International Group Inc.4,450$98K0.0%+50.5%0.026%
2/11/2021Northern Trust Corp82,247$1.81M0.0%+34.7%0.472%
2/11/2021Citigroup Inc.1,416$31K0.0%+495.0%0.008%
2/9/2021Wells Fargo & Company MN3,866$85K0.0%+138.5%0.022%
2/9/2021Bank of New York Mellon Corp26,319$0.58M0.0%+82.8%0.151%
2/8/2021New York State Common Retirement Fund6,400$0.14M0.0%+42.2%0.037%
2/5/2021BlackRock Inc.443,833$9.79M0.0%+31.0%2.550%
12/30/2020Deerfield Management Company L.P. Series C517,653$10.53M0.2%+22.1%2.974%
11/13/2020Charles Schwab Investment Management Inc.31,908$0.65M0.0%-2.4%0.183%
11/12/2020JPMorgan Chase & Co.3,107$68K0.0%-26.5%0.018%
11/10/2020State Street Corp64,013$1.30M0.0%+13.7%0.369%
11/9/2020SG Americas Securities LLC6,567$0.13M0.0%N/A0.038%
11/6/2020BlackRock Inc.338,793$6.89M0.0%-1.2%1.956%
11/5/2020California Public Employees Retirement System39,395$0.80M0.0%+2.1%0.227%
Data available starting January 2016

See Full Table
IMARA logo
Imara, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, which is an oral, once-a-day therapeutic for the treatment of sickle cell disease and b-thalassemia. The company was founded in 2016 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $12.50
$12.45
$13.03

50 Day Range

MA: $13.73
$12.33
$14.73

52 Week Range

Now: $12.50
$11.85
$62.71

Volume

57,154 shs

Average Volume

179,216 shs

Market Capitalization

$217.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of IMARA?

IMARA's top insider shareholders include:
  1. Rahul D Ballal (CEO)
  2. Barbara Dalton (Director)
  3. Bioscience Plc Arix (Major Shareholder)

Who are the major institutional investors of IMARA?

IMARA's top institutional investors include:
  1. BlackRock Inc. — 2.55%
  2. Northern Trust Corp — 0.47%
  3. Charles Schwab Investment Management Inc. — 0.20%
  4. Bank of New York Mellon Corp — 0.15%
  5. JPMorgan Chase & Co. — 0.12%
  6. New York State Common Retirement Fund — 0.04%

Which institutional investors are buying IMARA stock?

During the last quarter, IMRA stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. Northern Trust Corp
  3. JPMorgan Chase & Co.
  4. Bank of New York Mellon Corp
  5. Charles Schwab Investment Management Inc.
  6. Wells Fargo & Company MN
  7. New York State Common Retirement Fund
  8. American International Group Inc.
In the last year, these company insiders have bought IMARA stock:
  1. Rahul D Ballal (CEO)
  2. Barbara Dalton (Director)
Are you looking for the next great pet stock play?
Don't miss this opportunity as FRPT is already trading over 100 dollars per share!
Read more here about the next great pet stock!